LEADER 02013oam  2200541   450 
001 9910715471103321
005 20210412074756.0
024 8 $a38-120
035   $a(CKB)5470000002511331
035   $a(OCoLC)1243270141
035   $a(EXLCZ)995470000002511331
100   $a20210325d2021      ua             0
101 0 $aeng
135   $aur|||||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aLowering the cost of prescription drugs $ereducing barriers to market competition : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Sixteenth Congress, first session, March 13, 2019
210  1$aWashington :$cU.S. Government Publishing Office,$d2021.
215   $a1 online resource (vi, 246 pages)
300   $aAccess ID (govinfo): CHRG-116hhrg38120.
300   $a"Serial no. 116-17."
320   $aIncludes bibliographical references.
517   $aLowering the cost of prescription drugs 
606   $aPrescription pricing$zUnited States$xPublic opinion
606   $aDrugs$xGeneric substitution$xLaw and legislation$zUnited States
606   $aDrugs$xLaw and legislation$zUnited States
606   $aDrugs$zUnited States$xPatents
606   $aPatent laws and legislation$zUnited States
606   $aCompetition$zUnited States
606   $aPharmaceutical industry$zUnited States
608   $aLegislative hearings.$2lcgft
615  0$aPrescription pricing$xPublic opinion.
615  0$aDrugs$xGeneric substitution$xLaw and legislation
615  0$aDrugs$xLaw and legislation
615  0$aDrugs$xPatents.
615  0$aPatent laws and legislation
615  0$aCompetition
615  0$aPharmaceutical industry
801  0$bGPO
801  1$bGPO
801  2$bGPO
801  2$bOCLCO
801  2$bGPO
906   $aBOOK
912   $a9910715471103321
996   $aLowering the cost of prescription drugs$93449428
997   $aUNINA